296
Views
26
CrossRef citations to date
0
Altmetric
Original Article

Preparation of griseofulvin nanoparticle suspension by high-pressure homogenization and preservation of the suspension with saccharides and sugar alcohols

, , &
Pages 1022-1028 | Received 04 Jun 2008, Accepted 15 Dec 2008, Published online: 26 May 2009

References

  • Kim CK, Cho YJ, Gao ZG. (2001). Preparation and evaluation of biphenyl dimethyl dicarboxylate microemulsions for oral delivery. J Control Release, (1–2):149–55.
  • Kawakami K, Miyoshi K, Ida Y. (2004). Solubilization behavior of poorly soluble drugs with combined use of Gelucire 44/14 and cosolvent. J Pharm Sci, 93(6):1471–9.
  • Sheng JJ, Kasim NA, Chandrasekharan R, Amidon GL. (2006). Solubilization and dissolution of insoluble weak acid, ketoprofen: Effects of pH combined with surfactant. Eur J Pharm Sci, 29(3–4):306–14.
  • Jain P, Yalkowsky SH. (2007). Solubilization of poorly soluble compounds using 2-pyrrolidone. Int J Pharm, 342(1–2):1–5.
  • Cui SX, Nie SF, Li L, Wang CG, Pan WS, Sun JP. (2008). Preparation and evaluation of self-microemulsifying drug delivery system containing vinpocetine. Drug Dev Ind Pharm, 28:1–9.
  • Borhade VB, Nair HA, Hegde DD. (2008). Development and characterization of self-microemulsifying drug delivery system of tacrolimus for intravenous administration. Drug Dev Ind Pharm, 31:1–12.
  • Dixit RP, Nagarsenker MS. (2008). Formulation and in vivo evaluation of self-nanoemulsifying granules for oral delivery of a combination of ezetimibe and simvastatin. Drug Dev Ind Pharm, 34(12):1285–96.
  • Bashiri-Shahroodi A, Nassab PR, Szabó-Révész P, Rajkó R. (2008). Preparation of a solid dispersion by a dropping method to improve the rate of dissolution of meloxicam. Drug Dev Ind Pharm, 34(7):781–8.
  • Donato EM, Martins LA, Fröehlich PE, Bergold AM. (2008). Development and validation of dissolution test for lopinavir, a poorly water-soluble drug, in soft gel capsules, based on in vivo data. J Pharm Biomed Anal, 47(3):547–52.
  • Yamada T, Saito N, Imai T, Otagiri M. (1999). Effect of grinding with hydroxypropyl cellulose on the dissolution and particle size of a poorly water-soluble drug. Chem Pharm Bull, 47(9):1311–3.
  • Shu T, Suzuki H, Hironaka K, Ito K. (2002). Studies of rapidly disintegrating tablets in the oral cavity using co-ground mixtures of mannitol with crospovidone. Chem Pharm Bull, 50(2):193–8.
  • Friedrich H, Nada A, Bodmeier R. (2005). Solid state and dissolution rate characterization of co-ground mixtures of nifedipine and hydrophilic carriers. Drug Dev Ind Pharm, 31(8):719–28.
  • Vijaya Kumar SG, Mishra DN. (2006). Preparation, characterization and in vitro dissolution studies of solid systems of valdecoxib with chitosan. Chem Pharm Bull, 54(8):1102–6.
  • Garg A, Singh S, Rao VU, Bindu K, Balasubramaniam J. (2008). Solid state interaction of raloxifene HCl with different hydrophilic carriers during co-grinding and its effect on dissolution rate. Drug Dev Ind Pharm, 1:1–16.
  • Fujii M, Bouno M, Fujita S, Yoshida M, Watanabe Y, Matsumoto M. (2000). Preparation of griseofulvin for topical application using N-methyl-2-pyrrolidone. Bio Pharm Bull, 23(11):1341–5.
  • Atkinson RM, Bedford C, Child KJ, Tomich EG. (1962). Effect of particle size on blood griseofulvin-levels in man. Nature, 193:588–9.
  • Chattopadhyay P, Gupta RB. (2001). Production of griseofulvin nanoparticles using supercritical CO2 antisolvent with enhanced mass transfer. Int J Pharm, 228(1–2):19–31.
  • Eyjolfsson R. (1999). Nitrofurantoin: Particle size and dissolution. Drug Dev Ind Pharm, 25(1):105–6.
  • Rasenack N, Hartenhauer H, Müller BW. (2003). Microcrystals for dissolution rate enhancement of poorly water-soluble drugs. Int J Pharm, 254(2):137–45.
  • Perrut M, Jung J, Leboeuf F. (2005). Enhancement of dissolution rate of poorly-soluble active ingredients by supercritical fluid processes. Part I: Micronization of neat particles. Int J Pharm,, 288(1):3–10.
  • Hecq J, Deleers M, Fanara D, Vranckx H, Amighi K. (2005). Preparation and characterization of nanocrystals for solubility and dissolution rate enhancement of nifedipine. Int J Pharm, 299(1–2):167–77.
  • Peters K, Muller RH, Craig DQ. (1999). An investigation into the distribution of lecithins in nanosuspension systems using low frequency dielectric spectroscopy. Int J Pharm, 184(1):53–61.
  • Jacobs C, Kayser Q, Müller RH. (2000). Nanosuspensions as a new approach for the formulation for the poorly soluble drug tarazepide. Int J Pharm, 196(2):161–4.
  • Kraml M, Dubuc J, Gaudry R. (1962). Gastrointestinal absorption of griseofulvin. II. Influence of particle size in man. Antibiot Chemother, 12:239–42.
  • Jani P, Halbert GW, Langridge J, Florence AT. (1990). Nanoparticle uptake by the rat gastrointestinal mucosa: Quantitation and particle size dependency. J Pharm Pharmacol, 42:821–6.
  • Kwok KY, Adam RC, Hester KC, Park Y, Thomas S, Rice KG. (2000). Strategies for maintaining the particle size of peptide DNA condensates following freeze-drying. Int J Pharm, 203:81–8.
  • Konan YN, Gurny R, Allemann E. (2002). Preparation and characterization of sterile and freeze-dried sub-200 nm nanoparticles. Int J Pharm, 233:239–52.
  • Rasenack N, Müller BW. (2002). Dissolution rate enhancement by in situ micronization of poorly water-soluble drugs. Pharm Res, 19(12):1894–900.
  • Shekunov BY, Chattopadhyay P, Seitzinger J, Huff R. (2006). Nanoparticles of poorly water-soluble drugs prepared by supercritical fluid extraction of emulsions. Pharm Res, 23(1):196–204.
  • Chattopadhyay P, Huff R, Shekunov BY. (2006). Drug encapsulation using supercritical fluid extraction of emulsions. J Pharm Sci, 95(3):667–79.
  • Möschwitzer J, Müller RH. (2006). New method for the effective production of ultrafine drug nanocrystals. J Nanosci Nanotechnol, 6(9–10):3145–53.
  • Yang SC, Lu LF, Cai Y, Zhu JB, Liang BW, Yang CZ. (1999). Body distribution in mice of intravenously injected camptothecin solid lipid nanoparticles and targeting effect on brain. J Control Release, 59(3):299–307.
  • Rampon V, Riaublanc A, Anton M, Genot C, McClements DJ. (2003). Evidence that homogenization of BSA-stabilized hexadecane-in-water emulsions induces structure modification of the nonadsorbed protein. J Agric Food Chem, 51(20):5900–5.
  • Xu XM, Li Q, Zhu Y, Shen S, Shen Z, Yu JN. (2005). Study on the preparation and bio-distribution of silybin lipid nanospheres. Zhongguo Zhong Yao Za Zhi, 30(24):1912–4.
  • Hernández A, Harte FM. (2008). Manufacture of acid gels from skim milk using high-pressure homogenization. J Dairy Sci, 91(10):3761–7.
  • Nilsson L, Leeman M, Wahlund KG, Bergenståhl B. (2006). Mechanical degradation and changes in conformation of hydrophobically modified starch. Biomacromolecules, 7(9):2671–9.
  • Nozawa Y, Kamiya S, Sadzuka Y, Atsuo M, Sonobe T. (2004). Adding effect of saccharide to microsuspension particle size of griseofulvin-lipid mixtures subjected freeze-drying and rehydration. Kagaku Kogaku Ronbunshu, 30:43–6.
  • Adkins SS, Hobbs HR, Benaissi K, Johnston KP, Poliakoff M, Thomas NR. (2008). Stable colloidal dispersions of a lipase-perfluoropolyether complex in liquid and supercritical carbon dioxide. J Phys Chem B, 112(15):4760–9.
  • Hayes ME, Drummond DC, Hong K, Park JW, Marks JD, Kirpotin DB. (2006). Assembly of nucleic acid-lipid nanoparticles from aqueous-organic monophases. Biochim Biophys Acta, 1758(4):429–42.
  • Morale D, Capasso V, Oelschläger K. (2005). An interacting particle system modelling aggregation behavior: From individuals to populations. J Math Biol, 50(1):49–66.
  • Floyd R, Sharp DG. (1978). Viral aggregation: Quantitation and kinetics of the aggregation of poliovirus and reovirus. Appl Environ Microbiol, 35(6):1079–83.
  • Lomakin A, Teplow DB, Benedek GB. (2005). Quasielastic light scattering for protein assembly studies. Methods Mol Biol, 299:153–74.
  • Hayes ME, Drummond DC, Hong K, Park JW, Marks JD, Kirpotin DB. (2006). Assembly of nucleic acid-lipid nanoparticles from aqueous-organic monophases. Biochim Biophys Acta, 1758(4):429–42.
  • Wildman RD, Huntley JM, Hansen JP, Parker DJ, Allen DA. (2000). Single-particle motion in three-dimensional vibrofluidized granular beds. Phys Rev E Stat Phys Plasmas Fluids Relat Interdiscip Topics, 62(3 Pt B):3826–35.
  • Ellero M, Español P, Flekkøy EG. (2003). Thermodynamically consistent fluid particle model for viscoelastic flows. Phys Rev E Stat Nonlin Soft Matter Phys, 68(4 Pt 1):041504.
  • Witkoskie JB, Wu J, Cao J. (2004). Basis set study of classical rotor lattice dynamics. J Chem Phys, 120(12):5695–708.
  • Mauger A. (2005). Brownian motion in an aging medium. Phys Rev E Stat Nonlin Soft Matter Phys, 71(1 Part 1):011109.
  • Coffey WT, Kalmykov YP, Titov SV, Cleary L. (2008). Smoluchowski equation approach for quantum Brownian motion in a tilted periodic potential. Phys Rev E Stat Nonlin Soft Matter Phys, 78(3 Pt 1):031114.
  • Zhang H, Wang D, Butler R, Campbell NL, Long J, Tan B, al et. (2008). Formation and enhanced biocidal activity of water-dispersable organic nanoparticles. Nat Nanotechnol, 3(8):506–11.
  • Lim SB, Rubinstein I, Onyüksel H. (2008). Freeze drying of peptide drugs self-associated with long-circulating, biocompatible and biodegradable sterically stabilized phospholipid nanomicelles. Int J Pharm, 356(1–2):345–50.
  • Ueno K, Inaba A, Kondoh M, Watanabe M. (2008). Colloidal stability of bare and polymer-grafted silica nanoparticles in ionic liquids. Langmuir, 24(10):5253–9.
  • Lee J, Kim J, Park E, Jo S, Song R. (2008). PEG-ylated cationic CdSe/ZnS QDs as an efficient intracellular labeling agent. Phys Chem Chem Phys, 10(13):1739–42.
  • Gao L, Zhang D, Chen M, Zheng T, Wang S. (2007). Preparation and characterization of an oridonin nanosuspension for solubility and dissolution velocity enhancement. Drug Dev Ind Pharm, 33(12):1332–9.
  • Anhorn MG, Mahler HC, Langer K. (2008). Freeze drying of human serum albumin (HSA) nanoparticles with different excipients. Int J Pharm, 363(1–2):162–9.
  • Zhao XL, Chen HB, Chen YJ, Yang XL. (2007). [Freeze-drying of oleanolic acid-loaded nanosuspensions]. Zhongguo Zhong Yao Za Zhi, 32(18):1874–6.
  • Saez A, Guzmán M, Molpeceres J, Aberturas MR. (2000). Freeze-drying of polycaprolactone and poly (d,l-lactic-glycolic) nanoparticles induce minor particle size changes affecting the oral pharmacokinetics of loaded drugs. Eur J Pharm Biopharm, 50(3):379–87.
  • Teeranachaideekul V, Junyaprasert VB, Souto EB, Müller RH. (2008). Development of ascorbyl palmitate nanocrystals applying the nanosuspension technology. Int J Pharm, 354(1–2):227–34.
  • Oh KS, Han SK, Lee HS, Koo HM, Kim RS, Lee KE, al et. (2006). Core/Shell nanoparticles with lecithin lipid cores for protein delivery. Biomacromolecules, 7(8):2362–7.
  • Shaik MS, Ikediobi O, Turnage VD, McSween J, Kanikkannan N, Singh M. (2001). Long-circulating monensin nanoparticles for the potentiation of immunotoxin and anticancer drugs. J Pharm Pharmacol, 53(5):617–27.
  • Qiu L, Jing N, Jin Y. (2008). Preparation and in vitro evaluation of liposomal chloroquine diphosphate loaded by a transmembrane pH-gradient method. Int J Pharm, 361(1–2):56–63.
  • Lalanne M, Andrieux K, Paci A, Besnard M, Ré M, Bourgaux C, al et. (2007). Liposomal formulation of a glycerolipidic prodrug for lymphatic delivery of didanosine via oral route. Int J Pharm, 344(1–2):62–70.
  • Koo OM, Rubinstein I, Onyuksel H. (2005). Camptothecin in sterically stabilized phospholipid micelles: A novel nanomedicine. Nanomedicine, 1(1):77–84.
  • Crowe JH, Crowe LM. (1992). Preservation of liposomes by freeze-drying. In: Gregoriadis G, ed. Liposome technology, vol. 1, Liposome preparation and related techniques, 2nd. ed. Boca Raton: CRC Press; 229–52.
  • Cui Z, Hsu CH, Mumper RJ. (2003). Physical characterization and macrophage cell uptake of mannan-coated nanoparticles. Drug Dev Ind Pharm, 29(6):689–700.
  • Li B, Li S, Tan Y, Stolz DB, Watkins SC, Block LH, al et. (2000). Lyophilization of cationic lipid-protamine-DNA (LPD) complexes. J Pharm Sci, 89(3):355–64.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.